Therapeutic Drug Monitoring Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting therapeutic drug monitoring clinical trials across 5 countries. Studies span Phase 4, Not Applicable. Top locations include Amiens, France, Conakry, Guinea, Seoul, South Korea. Updated daily from ClinicalTrials.gov.


Therapeutic Drug Monitoring Trials at a Glance

7 actively recruiting trials for therapeutic drug monitoring are listed on ClinicalTrialsFinder across 4 cities in 5 countries. The largest study group is Phase 4 with 2 trials, with the heaviest enrollment activity in Amiens, Conakry, and Seoul. Lead sponsors running therapeutic drug monitoring studies include Nutromics Operations Pty Ltd, Asan Medical Center, and Centre Hospitalier Universitaire, Amiens.

Browse therapeutic drug monitoring trials by phase

Top cities for therapeutic drug monitoring trials

Treatments under study

About Therapeutic Drug Monitoring Clinical Trials

Looking for clinical trials for Therapeutic Drug Monitoring? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Therapeutic Drug Monitoring trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Therapeutic Drug Monitoring clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 4

Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment

Therapeutic Drug Monitoring (TDM)LinezolidTuberculosis Multi Drug Resistant Active
Marco Schiuma150 enrolled1 locationNCT07477119
Recruiting
Not Applicable

Ofloxacin Concentration-toxicity Relationship in the Elderly

Therapeutic Drug MonitoringBone and Joint InfectionOfloxacin+1 more
Centre Hospitalier Universitaire, Amiens110 enrolled1 locationNCT04496024
Recruiting

VANCORE: VANcomycin dosing study to CORrElate between compartments: a pilot characterisation study of a new device.

Therapeutic Drug Monitoring (TDM)
Nutromics Operations Pty Ltd12 enrolled1 locationACTRN12625000478415
Recruiting

Sub-Protocol #2 of Umbrella Protocol Study: Limit of Blank Characterization of Vancomycin Biosensor Nutromics Device.

Therapeutic Drug Monitoring
Nutromics Operations Pty Ltd50 enrolled1 locationACTRN12625000125426
Recruiting

Sub-Protocol #1 of Umbrella Protocol Study: Limit of Blank Characterization of Vancomycin Biosensor Nutromics Device.

Therapeutic Drug Monitoring
Nutromics Operations50 enrolled1 locationACTRN12625000115437
Recruiting
Phase 4

TDM-based Infliximab Treatment for Active Perianal Fistulizing Crohn's Disease

Crohn DiseasePerianal Fistula Due to Crohn's DiseaseInfliximab+2 more
Asan Medical Center86 enrolled1 locationNCT06051253
Recruiting

The Association Between Non-vitamin K Antagonist Oral Anticoagulant Therapy and Acute Stroke Severity and Post Stroke Short-term and Long-term Outcomes.

Therapeutic Drug Monitoring
National Taiwan University Hospital500 enrolled1 locationNCT05283174